Mufg Securities Americas Inc. Acquires New Holdings in STERIS plc (NYSE:STE)

Mufg Securities Americas Inc. acquired a new position in shares of STERIS plc (NYSE:STE - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,457 shares of the medical equipment provider's stock, valued at approximately $300,000.

Several other large investors have also recently added to or reduced their stakes in STE. Avalon Trust Co acquired a new stake in STERIS in the fourth quarter worth $30,000. Human Investing LLC acquired a new position in shares of STERIS during the fourth quarter valued at $31,000. Anfield Capital Management LLC increased its holdings in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares during the period. Manchester Capital Management LLC increased its holdings in shares of STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares during the period. Finally, Brown Brothers Harriman & Co. increased its holdings in shares of STERIS by 66.7% during the fourth quarter. Brown Brothers Harriman & Co. now owns 220 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 88 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Down 0.9%

Shares of STERIS stock traded down $2.19 during trading on Tuesday, hitting $250.36. 673,493 shares of the stock traded hands, compared to its average volume of 544,176. The stock has a market cap of $24.60 billion, a P/E ratio of 53.15 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a twelve month low of $200.98 and a twelve month high of $252.79. The company has a fifty day moving average price of $224.69 and a two-hundred day moving average price of $219.48.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.59 by $0.15. The business had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.47 billion. STERIS had a return on equity of 13.91% and a net margin of 8.66%. The firm's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company earned $2.58 EPS. Equities research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th will be issued a dividend of $0.57 per share. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 annualized dividend and a dividend yield of 0.91%. STERIS's dividend payout ratio is 36.77%.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Morgan Stanley raised their price target on STERIS from $240.00 to $260.00 and gave the company an "equal weight" rating in a report on Monday. Citigroup reiterated an "outperform" rating on shares of STERIS in a research report on Friday. Stephens reiterated an "overweight" rating and issued a $250.00 price target on shares of STERIS in a research report on Thursday, May 15th. Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, JMP Securities raised their price objective on STERIS from $265.00 to $280.00 and gave the stock a "market outperform" rating in a research report on Friday. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $264.00.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.